ArticleBreast cancer research and treatment2026

Risk of CNS relapse following pathological complete response to neoadjuvant chemotherapy in early breast cancer.

Luciana de Moura Leite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.